Buku Medicine Version 2

Buku Medicine has been running for 6 years now as an entirely voluntary platform to improve clinician workload and patient care. It is run by a team of 4 clinicians supported by excellent content contributors. We now have over 35,000 active users in the UK and abroad and this has put a burden on our current app platform.

In order to continue our work, we have had a new version of the App developed to cope with this workload and also offer us a means of sustainability. We will shortly be releasing this new (but still free!) version of the App which will continue to offer all of the same content you have had up to now, and soon will also be offering palliative care and neurology content. There will also be a search function which has been requested by many of our users.

Alongside this, we will be offering additional educational material which will be available behind a low cost annual subscription. This will cover different topics within our specialities, initially haematology only, and covers more about the conditions than the tests. It will help users understand the difference between a CLL and a CML for example, and key points about how these patients are cared for and disease trajectories. This will be offered as brief and standard written modules (the brief can be read in a minute or two for a brief intro or quick reminder of the topic), pictorial and video content. We have prepared almost 30 written modules, almost 40 videos and pictorial content for many of these with more to come. Users can also reflect on this content and generate a PDF of their reflections to submit to portfolios.

We will offer this content for a cost of just £4.99 per year

Our aim is to cover our costs, and continue to improve the App, offering the best possible service to the NHS and resource-poor healthcare environments. App development has been a significant cost, some of which our team are covering themselves at present. Your subscription (only 1.5 coffees per year!) will allow you access to the new educational content, and any further content to come in haematology and other specialties, but also allow us to maintain the free core content which has already had such a positive significant impact on referrals to specialties already.

Thank you for your ongoing support,

Alex, Steve, Kerri and Toby

Alexander Langridge